Reported covered position: Amy Efantis, L.D., Rep. Artur Davis
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Reform; Patent Settlements; H.R. 1706 and S. 5369
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Discussion with Chief Medical Officer -- Afibrulation
Miscellaneous Tariff Bill; relating to the duty suspensionof cyclopropylaminonicotine acid
Source: Senate LDA
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent reform, Patent settlements; H.R. 1706 and S. 5369
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
America's Affordable Health Choices Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, H.R. 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S. 1679: Senate HELP and S. 1796: Senate Finance committee drafts); pricing/rebates; importation; coverage; comparative effectiveness; biosimilars; transparency; 340B pricing; Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
America's Affordable Health Choices Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
Affordable Health Choices Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
Affordable Health Choices Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, H.R. 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S. 1679: Senate HELP and S. 1796: Senate Finance committee drafts); pricing/rebates; importation; coverage; comparative effectiveness; biosimilars; transparency; 340B pricing; Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
America's Healthy Future Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, H.R. 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S. 1679: Senate HELP and S. 1796: Senate Finance committee drafts); pricing/rebates; importation; coverage; comparative effectiveness; biosimilars; transparency; 340B pricing; Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
America's Healthy Future Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health Reform HR.1 American Recovery and Reinvestment Act focusing on Comparative Effectiveness and Trade President's Budget (see details on page 3) House/Senate Budget - H. Con. Res.85 President's Budget including Medicaid Rebates, Medicare Part D, Follow-on Biologics, Importation, Import Safety, Comparative Effectiveness, Patent Settlements, Intellectual Property Reform and Research Tax Credit.
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health Reform HR.1 American Recovery and Reinvestment Act focusing on Comparative Effectiveness and Trade President's Budget (see details on page 3) House/Senate Budget - H. Con. Res.85 President's Budget including Medicaid Rebates, Medicare Part D, Follow-on Biologics, Importation, Import Safety, Comparative Effectiveness, Patent Settlements, Intellectual Property Reform and Research Tax Credit.
Employee Free Choice Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Employee Free Choice Act - monitoring status of bill HR 1409 and S 560
Employee Free Choice Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Employee Free Choice Act - monitoring status of bill HR 1409 and S 560
Home Office Deduction Simplification Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R.1509, S.560 - Employee Free Choice Act
Home Office Deduction Simplification Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R.1509, S.560 - Employee Free Choice Act
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent reform, Patent settlements; H.R. 1706 and S. 5369
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent reform, Patent settlements; H.R. 1706 and S. 5369
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S.515 - Patent Reform Act H.R.1706 - Patent Settlement bill
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
patent reform, patent settlements; H.R. 1706 and S.5369
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S.515 - Patent Reform Act H.R.1706 - Patent Settlement bill
America's Affordable Health Choices Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
America's Affordable Health Choices Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
Protecting Employees and Retirees in Business Bankruptcies Act of 2010
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R.4677, Relating to duty suspension of cyclopropylanicotine acid; The Farm Bill (amendments to Lacey Act) Miscellaneous Trade Bill
Protecting Employees and Retirees in Business Bankruptcies Act of 2010
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R.4677, Relating to duty suspension of cyclopropylanicotine acid; The Farm Bill (amendments to Lacey Act) Miscellaneous Trade Bill
American Recovery and Reinvestment Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: (Affordable Health Choices Act), coverage,comparative effectiveness, pricing, rebates, bio-similars; Stimulus bill(s): American Recovery and Reinvestment Act - health IT and comparative effectiveness (HR 1 and S. 1)
Affordable Health Choices Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
Affordable Health Choices Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
America's Healthy Future Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
America's Healthy Future Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
Patent Reform Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S.515 - Patent Reform Act H.R.1706 - Patent Settlement bill
Patent Reform Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S.515 - Patent Reform Act H.R.1706 - Patent Settlement bill
Employee Free Choice Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R.1509, S.560 - Employee Free Choice Act
Employee Free Choice Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Employee Free Choice Act - monitoring status of bill HR 1409 and S 560
Employee Free Choice Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R.1509, S.560 - Employee Free Choice Act
Employee Free Choice Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Employee Free Choice Act - monitoring status of bill HR 1409 and S 560
Patent Reform Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S. 1145, Patent Reform Act of 2007 HR. 1908, Patent Reform Act of 2007
Patent Reform Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S. 1145, Patent Reform Act of 2007 H.R. 1908, Patent Reform Act of 2007
Food and Drug Import Safety Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
Fair Medicaid Drug Payment Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 3162, Children's Health and Medicare Protection Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.1951 & H.R. 3700, Fair Medicaid Drug Payment Act of 2007
To suspend temporarily the duty on Cyclopropylaminonicotinic acid.
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R.4677, Relating to duty suspension of cyclopropylaminonicotine acid; The Farm Bill (amendments to Lacey Act)
To suspend temporarily the duty on Cyclopropylaminonicotinic acid.
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 4677, relating to Duty Suspension of Cyclopropylaminonicotine acid
To suspend temporarily the duty on Cyclopropylaminonicotinic acid.
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 4677, Relating to duty suspension of cyclopropylaminonicotine acid; The Farm Bill (amendments to Lacey Act)
Stroke Treatment and Ongoing Prevention Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
False Claims Act Correction Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
The False Claims Act S. 2041 & HR 4854
Physician Payments Sunshine Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S. 2029 and H.R. 5605 - Physician Payments Sunshine Act of 2007
Physician Payments Sunshine Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
Safeguarding America's Pharmaceuticals Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
Medicare Improvements for Patients and Providers Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 3162, Children's Health and Medicare Protection Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.1951 & H.R. 3700, Fair Medicaid Drug Payment Act of 2007
Patent Reform Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S. 1145, Patent Reform Act of 2007 HR. 1908, Patent Reform Act of 2007
Patent Reform Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S. 1145, Patent Reform Act of 2007 H.R. 1908, Patent Reform Act of 2007
Fair Medicaid Drug Payment Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 3162, Children's Health and Medicare Protection Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.1951 & H.R. 3700, Fair Medicaid Drug Payment Act of 2007
Physician Payments Sunshine Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S. 2029 and H.R. 5605 - Physician Payments Sunshine Act of 2007
Physician Payments Sunshine Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
False Claims Act Correction Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
The False Claims Act S. 2041 & HR 4854
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
Medicare Improvements for Patients and Providers Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 3162, Children's Health and Medicare Protection Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.1951 & H.R. 3700, Fair Medicaid Drug Payment Act of 2007
Preserving Access to Medicare Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 3162, Children's Health and Medicare Protection Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.1951 & H.R. 3700, Fair Medicaid Drug Payment Act of 2007
Stroke Treatment and Ongoing Prevention Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
Farm Bill, Animal and Plant Inspection Service/Center for Veterinary Biologics, veterinary labeling issues
340B (Medicaid) Expansion
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Animal and Plant Health Inspection Service/Center for Veterinary Biologics; veterinary labeling issues
340B (Medicaid) Expansion
Miscellaneous Tariff Bill; relating to the duty suspension of cyclopropylaminonicotine acid
Patent Reform; Patent Settlements; H.R. 1706 and S. 5369
Health care reform; Patient Protection and Affordable Care Act implementation - pricing/rebates; importation; coverage; comparative effectiveness; biosimilars; transparency; 340B pricing; Independent Patient Advisory Board; Prescription Drug User Fee Act Reauthorization
Supplimentatl Appropriations Bill - patent settlements (no bill number at this stage)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Health care reform: America's Affordable Health Choices Act, H.R. 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S. 1679: Senate HELP and S. 1796: Senate Finance committee drafts); pricing/rebates; importation; coverage; comparative effectiveness; biosimilars; transparency; 340B pricing; Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
Miscellaneous Tariff Bill; relating to the duty suspension of cyclopropylaminonicotine acid
APHIS/CVB issues; veterinary labeling issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Health care reform; Patient Protection and Affordable Care Act implementation - pricing/rebates, importation, coverage, comparative effectiveness; biosimilars, transparency; 340B pricing, Independent Patient Advisory Board
Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
Farm Bill, Animal and Plant Health Inspection Service/Center for Veterinary Biologics, veterinary labeling issues
340B (Medicaid) Expansion
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Farm Bill, Animal and Plant Health Inspection Service/Center for Veterinary Biologics, veterinary labeling issues
Health care reform; Patient Protection and Affordable Care Act implementation - pricing/rebates, importation, coverage, comparative effectiveness; biosimilars, transparency; 340B pricing, Independent Patient Advisory Board
Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
340B (Medicaid) Expansion
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Health care reform: Patient Protection and Affordable Care Act implementation - pricing/rebates, importation, coverage, comparative effectiveness; biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; Prescription Drug User Fee Reauthorization
Farm Bill, Animal and Plant Health Inspection Service/Center for Veterinary Biologics, veterinary labeling issues
Miscellaneous Tariff Bill; relating to the duty suspension of cyclopropylaminonicotine acid
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369
Health care reform: Patient Protection and Affordable Care Act implementation - pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; Prescription Drug User Free Act Reauthorization
Animal and Plant Health Inspection Service / Center for Veterinary Biologics, veterinary labeling issues
340B (Medicaid) Expansion
Supplemental Appropriations Bill - patent settlements (no bill number at this stage)
Health care reform: Patient Protection and Affordable Care Act implementation - pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; Prescription Drug User Free Act Reauthorization
Patent reform, Patent settlements; H.R. 1706 and S. 5369
Miscellaneous Tariff Bill; relating to the duty suspension of cyclopropylaminonicotine acid
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
Employee Free Choice Act - monitoring status of bill HR 1409 and S 560
Miscellaneous Tariff Bill; relating to the duty suspension of cyclopropylaminonicotine acid
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
Miscellaneous Trade bill; relating to the duty suspension of cyclopropylaminonicotine acid
Health care reform: (Affordable Health Choices Act), coverage,comparative effectiveness, pricing, rebates, bio-similars; Stimulus bill(s): American Recovery and Reinvestment Act - health IT and comparative effectiveness (HR 1 and S. 1)
patent reform, patent settlements; H.R. 1706 and S.5369
Employee Free Choice Act
H.R.1509, S.560 - Employee Free Choice Act
S.515 - Patent Reform Act H.R.1706 - Patent Settlement bill
H.R.1 American Recovery and Reinvestment Act focusing on Comparative Effectiveness and Trade.
S.515 - Patent Reform Act H.R.1706 - Patent Settlement bill
H.R.1509, S.560 - Employee Free Choice Act
H.R.1 American Recovery and Reinvestment Act focusing on Comparative Effectiveness and Trade.
H.R.4677, Relating to duty suspension of cyclopropylaminonicotine acid; The Farm Bill (amendments to Lacey Act)
Protocol Amending the Convention Between the United States of America and Canada with Respect to Taxes on Income and on Capital (Treaty Doc. 110-15); The Bailout (R&D Tax Credit)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 4677, Relating to duty suspension of cyclopropylaminonicotine acid; The Farm Bill (amendments to Lacey Act)
Protocol Amending the Convention Between the United States of America and Canada with Respect to Taxes on Income and on Capital (Treaty Doc. 110-15); The Bailout (R&D Tax Credit)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR. 3162, Children's Health and Medicare Protection Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.1951 & H.R. 3700, Fair Medicaid Drug Payment Act of 2007
The False Claims Act S. 2041 & HR 4854
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
S. 1145, Patent Reform Act of 2007 HR. 1908, Patent Reform Act of 2007
Protocol Amending U.S. - Canada Income Tax Treaty
S. 2029 and H.R. 5605 - Physician Payments Sunshine Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
340B (Medicaid) Expansion
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Supplemental Appropriations Bill - patent settlements (no bill number at this stage)
340B (Medicaid) Expansion
Miscellaneous Tariff Bill; relating to the duty suspension of cyclopropylaminonicotine acid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Miscellaneous Tariff Bill; relating to the duty suspension of cyclopropylaminonicotine acid
Animal and Plant Health Inspection Service / Center for Veterinary Biologics, veterinary labeling issues
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APHIS/CVB issues, veterinary labeling issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Part D preservation in health reform Rebates, Medicare, Medicaid and Medicaid expansion in health reform
Patent reform, Patent settlements; H.R. 1706 and S. 5369
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Employee Free Choice Act - monitoring status of bill HR 1409 and S 560
Patent reform, Patent settlements; H.R. 1706 and S. 5369
Medicare Part D preservation in health reform Rebates, Medicare, Medicaid and Medicaid expansion in health reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Miscellaneous Trade bill; relating to the duty suspension of cyclopropylaminonicotine acid; The Farm bill (amendment to Lacey Act)
Medicare Part D preservation in health reform Rebates, Medicare, Medicaid and Medicaid expansion in health reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Health Reform HR.1 American Recovery and Reinvestment Act focusing on Comparative Effectiveness and Trade President's Budget (see details on page 3) House/Senate Budget - H. Con. Res.85 President's Budget including Medicaid Rebates, Medicare Part D, Follow-on Biologics, Importation, Import Safety, Comparative Effectiveness, Patent Settlements, Intellectual Property Reform and Research Tax Credit.
H.R.4677, Relating to duty suspension of cyclopropylanicotine acid; The Farm Bill (amendments to Lacey Act) Miscellaneous Trade Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Health Reform HR.1 American Recovery and Reinvestment Act focusing on Comparative Effectiveness and Trade President's Budget (see details on page 3) House/Senate Budget - H. Con. Res.85 President's Budget including Medicaid Rebates, Medicare Part D, Follow-on Biologics, Importation, Import Safety, Comparative Effectiveness, Patent Settlements, Intellectual Property Reform and Research Tax Credit.
H.R.4677, Relating to duty suspension of cyclopropylanicotine acid; The Farm Bill (amendments to Lacey Act) Miscellaneous Trade Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Reauthorization of the Animal Drug User Fee Act, no specific legislation
H.R. 4677, relating to Duty Suspension of Cyclopropylaminonicotine acid
Issues related to tariffs HS.4677, To suspend temporarily the dute on Cyclopropylaminonicotinic acid US-Canadian Tax Treaty
S. 1145, Patent Reform Act of 2007 H.R. 1908, Patent Reform Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of